Arrhythmias in the muscular dystrophies

被引:85
|
作者
Groh, William J. [1 ]
机构
[1] Indiana Univ, Dept Med, Div Cardiol, Krannert Inst Cardiol, Indianapolis, IN 46202 USA
关键词
Muscular dystrophy; Arrhythmia; Cardiomyopathy; Sudden death; Genetics; Pacemaker; Implantable cardioverter-defibrillator; CARDIAC MAGNETIC-RESONANCE; LAMIN-A/C GENE; MYOTONIC-DYSTROPHY; SUDDEN-DEATH; HEART; CARDIOMYOPATHY; SURVIVAL; TYPE-1; MECHANISMS; MORTALITY;
D O I
10.1016/j.hrthm.2012.06.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The muscular dystrophies are a group of inherited diseases affecting skeletal muscle that also affect cardiac muscle. Cardiac involvement occurs as a degenerative process with fibrosis and fatty replacement of the myocardium. Electrophysiologists are asked to participate in the care of muscular dystrophy patients because of the risk of atrial arrhythmias, conduction disease, bradycardia, ventricular arrhythmias, and sudden death. Duchenne, Becker, and limb-girdle types 2C-2F and 2I are muscular dystrophies in which the development of a dilated cardiomyopathy is common. Arrhythmias and conduction disease occur after the development of the dilated cardiomyopathy. Patients are considered for pacemakers or implantable cardioverter-defibrillators on the basis of guidelines used for nonischemic cardiomyopathies. Myotonic types 1 and 2, Emery-Dreifuss, limb-girdle type 1B, and facioscapulohumeral muscular dystrophies present with conduction disease and associated arrhythmias and variably with a dilated cardiomyopathy. In myotonic type 1, Emery-Dreifuss, and limb-girdle type 1B muscular dystrophies, conduction abnormalities are frequent and often require pacing. Recent studies support the use of prophylactic implantable cardioverter-defibrillators rather than pacemakers. In all the muscular dystrophies, respiratory muscle involvement can impact quality and quantity of life and needs to be factored in when considering a prophylactic device.
引用
收藏
页码:1890 / 1895
页数:6
相关论文
共 50 条
  • [41] Muscular dystrophies: an update on pathology and diagnosis
    Sewry, Caroline A.
    ACTA NEUROPATHOLOGICA, 2010, 120 (03) : 343 - 358
  • [42] Mechanisms of resistance to pathogenesis in muscular dystrophies
    Infante, JP
    Huszagh, VA
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 195 (1-2) : 155 - 167
  • [43] Diagnosis of Cardiac Abnormalities in Muscular Dystrophies
    Badila, Elisabeta
    Lungu, Iulia Ioana
    Grumezescu, Alexandru Mihai
    Scafa Udriste, Alexandru
    MEDICINA-LITHUANIA, 2021, 57 (05):
  • [44] Risk of fracture in patients with muscular dystrophies
    S. Pouwels
    A. de Boer
    H. G. M. Leufkens
    W. E. J. Weber
    C. Cooper
    H. A. W. van Onzenoort
    F. de Vries
    Osteoporosis International, 2014, 25 : 509 - 518
  • [45] Cardiac MR Imaging of Muscular Dystrophies
    Sanchez, Felipe
    Weitz, Carolina
    Gutierrez, Jose M.
    Mestroni, Luisa
    Hanneman, Kate
    Vargas, Daniel
    CURRENT PROBLEMS IN DIAGNOSTIC RADIOLOGY, 2021, 51 (02) : 225 - 234
  • [46] Fatigue in muscular dystrophies
    Angelini, Corrado
    Tasca, Elisabetta
    NEUROMUSCULAR DISORDERS, 2012, 22 : S214 - S220
  • [47] Pericytes in Muscular Dystrophies
    Moyle, Louise Anne
    Tedesco, Francesco Saverio
    Benedetti, Sara
    PERICYTE BIOLOGY IN DISEASE, 2019, 1147 : 319 - 344
  • [48] Cardiomyopathy in muscular dystrophies
    Muntoni, F
    CURRENT OPINION IN NEUROLOGY, 2003, 16 (05) : 577 - 583
  • [49] Quality of life in adult patients with limb-girdle muscular dystrophies
    Peric, Marina
    Peric, Stojan
    Stevanovic, Jelena
    Milovanovic, Sara
    Basta, Ivana
    Nikolic, Ana
    Kacar, Aleksandra
    Rakocevic-Stojanovic, Vidosava
    ACTA NEUROLOGICA BELGICA, 2018, 118 (02) : 243 - 250
  • [50] Morphologic imaging in muscular dystrophies and inflammatory myopathies
    Degardin, Adrian
    Morillon, David
    Lacour, Arnaud
    Cotten, Anne
    Vermersch, Patrick
    Stojkovic, Tanya
    SKELETAL RADIOLOGY, 2010, 39 (12) : 1219 - 1227